The Diagnostics Boom Meets the 'Unquantified Self'
Two funding rounds this week underscore how much capital is still chasing biometric monitoring: Hilo, the Fitbit-style blood-pressure wearable, closed a $19M Series B extension (pushing its total raised past $119M), while smart-toilet health-sensor startup Casana landed $46M on a bet that continuous at-home diagnostics is a billion-dollar category. At the same time, Global Wellness Summit's latest trend digest documents a growing consumer counter-movement — clients who describe wanting to 'trust their own body' over dashboards and scores, alongside rising skepticism toward AI-generated wellness influencers pushing that same data-driven aesthetic. The split matters commercially: longevity and medical-wellness properties building diagnostics-heavy protocols sit on one side of a widening client divide, while destination spas positioned around device-free, analog time in nature sit on the other. Advisors should be asking upfront whether a client wants more measurement or a break from it — the wrong match undercuts the program before it starts.
- Hilo: $19M Series B extension, total raised over $119M — blood-pressure wearable
- Casana: $46M raised for a sensor-equipped 'smart toilet' health platform
- Global Wellness Summit trend data flags a parallel backlash against self-tracking and AI-generated wellness content